We will offer a 240-marker, direct-to-provider DNA panel that focuses on the identification and prevention of common maternal complications, ranging from gestational diabetes and preterm birth to mental health conditions and opioid addiction. Providers will be given specific, actionable recommendations. We plan to target self-insured businesses and provide the service at a reasonable price (our cost: $80/sample for all consumable materials).